Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
4548 On Other Exchanges
Symbol
Exchange
4548 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

seikagaku corp (4548) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SEIKAGAKU CORP (4548)

Related News

No related news articles were found.

seikagaku corp (4548) Related Businessweek News

No Related Businessweek News Found

seikagaku corp (4548) Details

Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan. The company operates through Pharmaceutical and LAL segments. It offers pharmaceuticals and medical devices, such as intra-articular injections for improving joint functions under the brand names of ARTZ, ARTZ Dispo, SUPARTZ, ARTZAL, etc.; an injection medical device for treatment of osteoarthritis pain of the knee under the brand name of Gel-One; OPEGAN branded ophthalmic surgical aids; and MucoUp branded surgical aid for endoscopic mucosal resection. The company also provides bulk products consisting of hyaluronic acid, which is primarily used as a raw material of joint function improving agents, ophthalmic surgical aids, and ophthalmic products; and chondroitin sulfate that is used as a raw material in ophthalmic products comprising eye drops and eyewashes, drinks for nutritional fortifications, etc. In addition, it develops endotoxin-detecting reagents under various brands, including the Pyrochrome, ENDOSPECY, TOXICOLOR, etc. for quality control in the manufacturing process and release test of pharmaceuticals and medical devices, as well as dialysis fluid. Further, Seikagaku Corporation develops and markets oral care products comprising mouthwash under the KINUSUI Spray brand. It also exports its products to various countries. The company was formerly known as K.K. Seikagaku Kenkyusho and changed its name to Seikagaku Corporation in 1962. Seikagaku Corporation was founded in 1947 and is headquartered in Tokyo, Japan.

649 Employees
Last Reported Date: 06/19/15
Founded in 1947

seikagaku corp (4548) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

seikagaku corp (4548) Key Developments

Seikagaku Corp., Annual General Meeting, Jun 19, 2015

Seikagaku Corp., Annual General Meeting, Jun 19, 2015.

Seikagaku Corp. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2015; Provides Earnings Guidance for the Six Months and Full Year Ending March 31, 2016 and Dividend Guidance for the Second Quarter and Full Year Ending March 31, 2016; Declares Cash Dividend for the Year Ended March 31, 2015, Payable on June 22, 2015

Seikagaku Corp. reported consolidated and non-consolidated earnings results for the year ended March 31, 2015. For the year, on consolidated basis, the company reported net sales of JPY 29,522 million against JPY 29,614 million a year ago. Operating income was JPY 2,383 million against JPY 4,937 million a year ago. Ordinary income was JPY 4,008 million against JPY 5,878 million a year ago. Net income was JPY 3,650 million or JPY 64.27 per share against JPY 4,745 million or JPY 83.55 per share a year ago. Return on equity was 5.4% against 7.5% a year ago. Net cash flows from operating activities were JPY 4,132 million against JPY 6,406 million a year ago. For the year, on non-consolidated basis, the company reported net sales of JPY 25,992 million against JPY 26,638 million a year ago. Operating income was JPY 1,509 million against JPY 4,304 million a year ago. Ordinary income was JPY 3,145 million against JPY 5,247 million a year ago. Net income was JPY 3,058 million or JPY 53.84 per share against JPY 4,360 million or JPY 76.77 per share a year ago. For the first six-month of fiscal 2015, the company expects consolidated net sales of JPY 15,750 million, operating income of JPY 1,750 million, ordinary income of JPY 2,250 million and net income of JPY 1,700 million or JPY 29.93 per share. For the year ending March 31, 2016, the company expects consolidated net sales of JPY 30,650 million, operating income of JPY 2,400 million, ordinary income of JPY 3,800 million and net income of JPY 2,900 million or JPY 51.05 per share. For the second quarter of 2015, the company expects to pay dividend of JPY 13.00 per share. For the year 2015, the company expects to pay dividend of JPY 13.00 per share. The company declared a cash dividend of JPY 13.00 per share for the year ended March 31, 2015, payable on June 22, 2015.

Seikagaku Corp., 2015 Earnings Call, May 15, 2015

Seikagaku Corp., 2015 Earnings Call, May 15, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4548:JP ¥1,928.00 JPY -2.00

4548 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Zimmer Biomet Holdings Inc $106.50 USD +0.72
View Industry Companies
 

Industry Analysis

4548

Industry Average

Valuation 4548 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEIKAGAKU CORP, please visit www.seikagaku.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.